MedPal AI has acquired eMARx to complete its Health OS, linking NHS prescriptions to dispensing, delivery and barcode-verified eMARs to strengthen AI-driven medication management in UK care homes.
MedPal AI Acquires eMARx to Complete Health OS and Advance AI Medication Management Read More »
Discover how Taiwan’s medtech startups use AI to speed and sharpen diagnostics—handheld AI ultrasound, real-time surgical image recognition, and practical gains for clinicians.
AI Pushes Diagnostic Frontiers: Taiwan’s Medtech Innovations Read More »
BeCertain secures £1.7M pre-seed backing to commercialise its uncertainty-aware AI for 2D dental X-ray interpretation, aiming to improve diagnostic reliability.
AI Investment Advances Dental Diagnostics as BeCertain Raises £1.7M Read More »
A major UK study finds mixed public views on AI scribes. Patients demand clear consent, clinician checks for accuracy, and opt-outs for sensitive consultations.
Patient Trust in AI Scribes: Public Concerns and Conditional Support Read More »
Explore how AI is transforming drug discovery — from target ID to smarter clinical trials — cutting time and cost while improving patient outcomes. A concise outlook for healthcare leaders and investors.
AI Drug Discovery: How Machine Learning Is Speeding Up New Medicines Read More »
AI is reshaping clinical care but also shifting responsibility for patient outcomes. Read a concise guide for clinicians and health leaders on human oversight, documentation, informed consent, and organisational risk steps to manage AI-related liability.
AI in Healthcare: Who Is Responsible When Algorithms Err? Read More »
Philips Future Health Index 2026: UK clinicians report time savings and more patients, yet training, infrastructure and governance shortfalls risk safe AI scaling.
AI’s Dual Impact: UK Healthcare Sees Gains but Readiness Gaps Persist Read More »
A concise, realistic guide to where AI adds measurable value in drug discovery: data enrichment, experiment prioritization, and multi-parameter optimization. Practical limits and steps for teams.
AI in Drug Discovery: Practical Value, Not Hype Read More »
A new multimodal AI platform delivered faster, more accurate diagnoses in a multicenter trial. What clinicians and health systems should watch next.
Multimodal AI Platform Cuts Diagnostic Time in Multicenter Trial Read More »
Shanghai and Hong Kong launch a cross-border AI and biotech bootcamp that pairs Hong Kong R&D with Shanghai commercialization to speed health AI innovations to market.
